Edolf Pharma Private Limited

Edolf Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24239CH2019PTC042635 Incorporated 22 July 2019 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹77.23 Lakh
▲ 73% YoY
Net loss · FY 2024
₹2.12 Lakh
Net margin -2.7%
EBITDA · FY 2024
₹3.06 Lakh
EBITDA margin 4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Edolf Pharma Private Limited

Data last updated:

Edolf Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH2019PTC042635. Its GSTIN is 04AAFCE5732R1Z9 (Chandigarh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jasvinder Kaur and Babli Devi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cabin No.106 2nd Floor Building No. 702 Kesho Ram Complex Village Burail, Chandigarh, India – 160047.

As per the financials filed for FY 2024, the company reported a revenue of ₹77.23 Lakh, a growth of 73% compared to the previous year. For the same year it recorded a net loss of ₹2.12 Lakh (net margin -2.7%) and EBITDA of ₹3.06 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 132% over three years.

As per MCA filings, the company has open charges of ₹50 Lakh on record.

Edolf Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0015258).

Company Details of Edolf Pharma Private Limited
CIN U24239CH2019PTC042635
Registration Number 042635
Incorporation Date 22 July 2019
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0015258

Recognitions & Rankings of Edolf Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-CH-01-0015258
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Cabin No.106 2nd Floor Building No. 702 Kesho Ram Complex Village Burail, Chandigarh, India – 160047
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Edolf Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Edolf Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Edolf Pharma Private Limited in one report.

Financials from FY 2020 Directors & ownership Charges & compliance

Business Activity of Edolf Pharma Private Limited

The main business activity of Edolf Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Edolf Pharma Private Limited FY 2025 filings available

Edolf Pharma Private Limited reported revenue of ₹77.23 Lakh (up 73% YoY) for FY 2024.

Revenue · FY 2024
₹77.23 Lakh ▲ 73%
Net loss · FY 2024
₹2.12 Lakh margin -2.7%
EBITDA · FY 2024
₹3.06 Lakh margin 4%

Compounded Annual Growth Rate (CAGR) of Edolf Pharma Private Limited

Revenue CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 132%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 210%

Revenue has grown at a compounded annual rate (CAGR) of 132% over three years, including 73% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Edolf Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.06 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹2.12 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Edolf Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4%••••••••••••••••
Net Profit Margin-2.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Edolf Pharma are in the company report.

Premium access

Financial statements from FY 2020

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Edolf Pharma Private Limited

Edolf Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jasvinder KaurDirector22 Jul 20197 Years 2 MonthsCurrent
Babli DeviDirector22 Jul 20197 Years 2 MonthsCurrent

Peer Comparison of Edolf Pharma Private Limited

Edolf Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pharm Biosis Private Limited₹77.86 Lakh (FY 2022)••••••••613.0%••••Ahmedabad, Gujarat, India
Nuak Laboratories Pvt Ltd₹77.61 Lakh (FY 2024)••••••••-4.0%••••Paraganas, West Bengal, India
Novaarc Surgicals Private Limited₹77.58 Lakh (FY 2021)••••••••-48.0%••••Bengaluru, Karnataka, India
Leogen Biotics Private Limited₹77.43 Lakh (FY 2024)••••••••93.0%••••Delhi, India
Shripad Medi-Search Private Limited₹77.26 Lakh (FY 2025)••••••••19.0%••••Pune, Maharashtra, India
Edolf Pharma Private Limited this company₹77.23 Lakh (FY 2024)••••••••73.0%••••Chandigarh, India
Nodysis Lifescience Private Limited₹77.11 Lakh (FY 2025)••••••••6.0%••••Bhubaneswar, Odisha, India
Rekvina Pharmaceuticals (India) Private Limited₹77 Lakh (FY 2023)••••••••4375.0%••••Mumbai, Maharashtra, India
Zwitt Pharmaceuticals Private Limited₹76.81 Lakh (FY 2025)••••••••141.0%••••Ahmedabad, Gujarat, India
Ultra Aero Products Private Limited₹76.78 Lakh (FY 2025)••••••••-13.0%••••Mumbai, Maharashtra, India
Biozest Healthcare Private Limited₹76.78 Lakh (FY 2025)••••••••131.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Edolf Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Edolf Pharma Private Limited

Edolf Pharma Private Limited is audited by AARYAA & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
AARYAA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Edolf Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Edolf Pharma Private Limited

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Yes Bank Limited₹0.50 Cr
Latest charge details
DateLenderAmountStatus
07 Jan 2026Yes Bank Limited₹50 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Edolf Pharma Private Limited

Employment history and EPFO contributions of people linked to Edolf Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Edolf Pharma Private Limited

Edolf Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Babli Devi was appointed as Director on 22 Jul 2019.

Charges
A charge with Yes Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 101217554 was registered on 07 Jan 2026.
AGM
Edolf Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Edolf Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Babli Devi was appointed as Director.
Appointed
Jasvinder Kaur was appointed as Director.
Incorporation
22 Jul 2019
Edolf Pharma Private Limited was registered on 22 Jul 2019 with Roc Chandigarh & aged 7 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Edolf Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Edolf Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Edolf Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Edolf Pharma Private Limited

Edolf Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AAFCE5732R1Z9ChandigarhActive23 Sep 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Edolf Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Edolf Pharma Private Limited

Edolf Pharma is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2019 (7+ years old) and is registered under CIN U24239CH2019PTC042635.

Edolf Pharma reported revenue of ₹77.23 Lakh for FY 2024 (up 73% YoY).

Edolf Pharma has 2 current directors:

Edolf Pharma reported a net loss of ₹2.12 Lakh (net margin -2.7%) and EBITDA of ₹3.06 Lakh (EBITDA margin 4%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Edolf Pharma is 132% over three years. In the latest year (FY 2024) revenue rose 73%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Edolf Pharma is 04AAFCE5732R1Z9, registered in Chandigarh.

The CIN (Corporate Identification Number) of Edolf Pharma is U24239CH2019PTC042635. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Edolf Pharma was incorporated on 22 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Edolf Pharma by revenue are Pharm Biosis Private Limited, Nuak Laboratories Pvt Ltd, Novaarc Surgicals Private Limited, Leogen Biotics Private Limited, Shripad Medi-Search Private Limited and 5 more, all in the Pharma industry (Formulations).

Babli Devi was appointed as Director on 22 Jul 2019. Jasvinder Kaur was appointed as Director on 22 Jul 2019.

Yes, Edolf Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0015258).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available